ESC Premium Access

Treatment intensity in primary and secondary prevention? The role of precision medicine.

Congress Presentation

About the speaker

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
50 presentations
3 followers

3 more presentations in this session

Should we address other lipid/lipoproteins besides LDL-C?

Speaker: Professor R. Frikke-Schmidt (Copenhagen, DK)

Thumbnail

When should we add PCSK-9 inhibitors?

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Is there a place for anti-inflammatory medication in clinical practice?

Speaker: Professor K. Ray (London, GB)

Thumbnail

Access the full session

Lipid-lowering therapy: how to tailor treatment to your patient

Speakers: Professor J. Deanfield, Professor R. Frikke-Schmidt, Professor S. Nicholls, Professor K. Ray
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb